2) biodegradable microspheres
可生物降解缓释微球
3) slow-release membrane
缓释膜
1.
In vitro antibacterial activities and in vivo release rate of the ornidazole slow-release membranes;
奥硝唑缓释膜体外抑菌性及体内释放度的研究
2.
To introduce the preparation and quality control methods of the ornidazole slow-release membranes which take CM-chitosan as carriers.
研制以羧甲基壳聚糖为载体的奥硝唑缓释膜(药膜,下同)并建立质量控制方法。
4) release drug membrane
缓释药膜
1.
After performed the release drug membrane resisting scar implantion in rabbits , we investigated the efficacy and security of the release drug membrane resisting scar through observed intraocular pressure and the number of f.
本实验目的是含地塞米松不同浓度以甲壳素制成的缓释膜放入兔青光眼术中结膜下,观察缓释药膜抑制滤过泡周围成纤维细胞增生作用,为青光眼术后抗滤过泡增生的治疗提供实验依据。
6) delayed degradation
缓降解
1.
Objective:Using delayed degradation bone matrix gelatin (BMG) to repair the defect of laryngeal frame for the goal of laryngeal external form and function recovery.
目的:利用缓降解骨基质明胶(BMG)修复喉框架缺损,以达到恢复喉的外形和功能的目的。
补充资料：可降解淀粉微球和生物降解白蛋白微球阻滞法
可降解淀粉微球和生物降解白蛋白微球阻滞法
介入放射学技术。介入性局部化疗之前，把二者注入靶动脉，可暂时减少动脉血流，再行化疗药物灌注，以减少血液冲刷，保持局部化疗药物浓度的技术。与其他中期和长期栓塞微球不同，DSM和BAM仅造成数十分钟的血流量减少，待其被降解后血流可恢复至以前水平。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条